Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Momenta Pharma (MNTA)

Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,246,641
  • Shares Outstanding, K 119,029
  • Annual Sales, $ 23,870 K
  • Annual Income, $ -290,060 K
  • 60-Month Beta 1.78
  • Price/Sales 261.77
  • Price/Cash Flow N/A
  • Price/Book 15.63
Trade MNTA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.23
  • Most Recent Earnings $-0.45 on 10/31/19
  • Latest Earnings Date 10/29/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.47
  • Number of Estimates 6
  • High Estimate -0.43
  • Low Estimate -0.51
  • Prior Year -0.56
  • Growth Rate Est. (year over year) +16.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.02 +0.88%
on 09/11/20
52.53 -0.10%
on 09/30/20
+0.15 (+0.29%)
since 08/28/20
3-Month
26.86 +95.38%
on 08/11/20
52.53 -0.10%
on 09/30/20
+19.21 (+57.74%)
since 06/30/20
52-Week
12.21 +329.81%
on 10/02/19
52.53 -0.10%
on 09/30/20
+39.52 (+304.94%)
since 09/30/19

Most Recent Stories

More News
Momenta Pharmaceuticals Announces Completion of Proposed Sale to Johnson & Johnson

CAMBRIDGE, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA, “Momenta” or the “Company”), a biotechnology company focused on discovering and developing novel...

MNTA : 52.48 (-0.02%)
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – MNTA, VRTU, AIMT, MXIM

NEW YORK, NY / ACCESSWIRE / September 20, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) concerning potential violations of the...

MNTA : 52.48 (-0.02%)
VRTU : 51.33 (+0.03%)
AIMT : 34.49 (-0.29%)
MXIM : 103.14 (-1.18%)
Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Rosetta Stone, Momenta, Jernigan, and Varian on behalf of Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of Rosetta Stone Inc. (NYSE: RST), Momenta...

RST : 29.99 (unch)
MNTA : 52.48 (-0.02%)
JCAP : 17.22 (-0.23%)
VAR : 177.07 (-0.02%)
Momenta Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Proposed Sale to Johnson & Johnson

CAMBRIDGE, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA, “Momenta” or the “Company”), a biotechnology company focused on discovering and developing...

MNTA : 52.48 (-0.02%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – MNTA, BMCH, RST, AIMT

NEW YORK, NY / ACCESSWIRE / September 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) concerning potential violations...

MNTA : 52.48 (-0.02%)
BMCH : 53.68 (-3.24%)
RST : 29.99 (unch)
AIMT : 34.49 (-0.29%)
Moore Kuehn Encourages MNTA, AIMT, ONDK, and OTEL Investors to Contact Law Firm

NEW YORK, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...

MNTA : 52.48 (-0.02%)
AIMT : 34.49 (-0.29%)
ONDK : 1.8300 (-3.17%)
OTEL : 11.74 (+0.15%)
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – VAR, JCAP, MNTA, BYFC

NEW YORK, NY / ACCESSWIRE / September 1, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Varian Medical Systems, Inc. (NYSE:VAR) concerning potential violations of...

VAR : 177.07 (-0.02%)
JCAP : 17.22 (-0.23%)
MNTA : 52.48 (-0.02%)
BYFC : 4.88 (-2.98%)
Lifshitz Law Firm, P.C. Announces Investigation of Cancer Genetics, Inc., Momenta Pharmaceuticals, Inc., Principia Biopharma Inc., and Yintech Investment Holdings Limited

NEW YORK, Sept. 01, 2020 (GLOBE NEWSWIRE) --

CGIX : 4.61 (-2.33%)
MNTA : 52.48 (-0.02%)
PRNB : 100.05 (+0.10%)
YIN : 7.25 (+0.14%)
SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – PRNB, MNTA, PTI, BLDR

NEW YORK, NY / ACCESSWIRE / August 29, 2020 /Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Principia Biopharma Inc. (NASDAQ:PRNB) concerning potential violations of the...

PRNB : 100.05 (+0.10%)
MNTA : 52.48 (-0.02%)
PTI : 1.1100 (-3.48%)
BLDR : 177.03 (-2.88%)
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – CBMG, PRNB, MNTA, PTI

NEW YORK, NY / ACCESSWIRE / August 25, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) concerning potential violations...

CBMG : 19.75 (unch)
PRNB : 100.05 (+0.10%)
MNTA : 52.48 (-0.02%)
PTI : 1.1100 (-3.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Momenta Pharmaceuticals is a leader in the analysis, characterization and design of complex pharmaceutical products. Their scientific foundation is a set of tools and methods that allow them to develop a deep understanding of the links between a compound's chemical structure, biological function and...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 52.56
1st Resistance Point 52.52
Last Price 52.48
1st Support Level 52.45
2nd Support Level 52.42
3rd Support Level N/A

See More

52-Week High 52.53
Last Price 52.48
Fibonacci 61.8% 37.13
Fibonacci 50% 32.37
Fibonacci 38.2% 27.61
52-Week Low 12.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar